Talin1–Piezo1–YAP Axis: Calcium-Driven Endothelial Inflammation in Atherosclerosis

Study Background and Research Question

Atherosclerosis is a progressive inflammatory disease of the arteries that remains a leading cause of cardiovascular morbidity and mortality worldwide. While lipid-lowering therapies have reduced some burden, the persistence of adverse cardiovascular events underscores the need for more targeted interventions. Vascular endothelial cell dysfunction is a central initiator of atherosclerotic plaque formation, yet the molecular drivers of endothelial inflammation remain incompletely characterized. Mechanotransduction—the process by which cells convert mechanical stimuli into biochemical signals—has emerged as a critical contributor, but the precise molecular axis linking mechanical forces, calcium influx, and pro-inflammatory gene activation has not been fully delineated. The reference study by Wang et al. (Cellular and Molecular Life Sciences, 2026) specifically interrogates the role of Talin1 and its interaction with the Piezo1–YAP signaling axis in regulating endothelial inflammation and atherosclerosis.

Key Innovation from the Reference Study

The principal innovation of the reference study is the identification of Talin1 as a mechanosensitive mediator that integrates calcium influx via the Piezo1 channel with downstream activation of YAP (Yes-associated protein), a transcriptional regulator of inflammation. By mapping the molecular cascade from extracellular mechanical stress and inflammatory stimuli to the activation of pro-inflammatory gene expression, the authors highlight a previously underappreciated axis—Talin1–Piezo1–YAP—that is critical for endothelial cell inflammatory responses in atherosclerosis. This mechanistic insight expands the therapeutic landscape, positioning Talin1 as a promising target for anti-inflammatory strategies in vascular disease.

Methods and Experimental Design Insights

The investigators employed a multifaceted experimental approach combining in vivo, ex vivo, and in vitro systems to dissect the role of Talin1 in vascular inflammation. Key methodological highlights include:

• Animal Model of Atherosclerosis: ApoE-knockout (ApoE-KO) mice underwent partial carotid artery ligation to induce low oscillatory shear stress (OSS), recreating the hemodynamic environment conducive to plaque formation. Talin1 expression was assessed in atherosclerotic lesions and serum.
• Human Endothelial Cell Culture: Human aortic (HAEC) and umbilical vein endothelial cells (HUVEC) were exposed to tumor necrosis factor α (TNF-α) and OSS to model inflammatory activation in vitro.
• Genetic Manipulation: Lentiviral vectors were used for Talin1 knockdown to ascertain its causal role in mediating inflammatory responses.
• Calcium Influx Assays: The activation of Piezo1 and resultant intracellular calcium changes were monitored, linking mechanical and chemical cues to downstream signaling events.
• Inflammatory Marker Quantification: The expression of key adhesion molecules (ICAM1, VCAM1) and YAP activation was measured to evaluate pro-inflammatory outcomes.

This rigorous experimental framework enabled a detailed mapping of the Talin1–Piezo1–YAP signaling cascade in the context of atherosclerotic inflammation.

Core Findings and Why They Matter

The study’s results offer several significant advances:

• Elevated Talin1 in Atherosclerosis: Both human patients with coronary heart disease and ApoE-KO mice with induced atherosclerosis exhibited increased serum and endothelial Talin1 levels, supporting its relevance in clinical and experimental atherosclerosis.
• Talin1 is Required for Endothelial Inflammatory Activation: Endothelial cells subjected to TNF-α or OSS displayed increased inflammatory marker expression, but this response was abolished when Talin1 was knocked down, indicating its essential role.
• Piezo1-Mediated Calcium Influx is Upstream: The study confirmed that both TNF-α and OSS activate Piezo1, leading to increased cytosolic calcium, which in turn stimulates Talin1 and subsequently YAP activation.
• YAP as a Downstream Effector: YAP activation was necessary for the full inflammatory gene response, positioning it as the terminal node in this mechanotransductive axis.

By clarifying Talin1’s position as a transducer between calcium influx and gene regulation, the findings underscore the importance of precise control over calcium signaling in vascular inflammation and open avenues for targeted anti-inflammatory interventions.

Comparison with Existing Internal Articles

The Talin1–Piezo1–YAP axis described in this study complements and extends several internal research articles focused on calcium signaling in vascular and neuronal contexts. For example, "Talin1–Piezo1–YAP Axis in Endothelial Inflammation and Atherosclerosis" provides a broader overview, confirming that Talin1 is a mechanosensitive mediator linking calcium influx to inflammatory gene expression. The reference study distinguishes itself by deploying genetic knockdown models and direct mechanistic assays to validate this axis in both animal and human endothelial cells.

Furthermore, articles such as "EGTA as a Precision Calcium Chelator: Advanced Neuroprote..." and "EGTA (Egtazic Acid): Precision Calcium Chelation in Cell Assays" discuss the utility of selective calcium chelators like EGTA (egtzic acid) in dissecting calcium-dependent pathways and inhibiting nitric oxide-induced calcium influx—a mechanism highly relevant to the Piezo1 activation events characterized in the reference study. These internal resources reinforce the necessity of precise calcium modulation for unraveling cell signaling networks in both vascular and neurological models.

Limitations and Transferability

While the reference study provides robust evidence linking Talin1 to the Piezo1–YAP pathway in endothelial inflammation, several limitations merit consideration. The primary models employed—ApoE-KO mice and cultured endothelial cells—recapitulate key aspects of atherosclerosis but may not fully reflect the complexity of human vascular disease. The study’s focus on a single signaling cascade, while necessary for mechanistic clarity, does not address potential crosstalk with other inflammatory or mechanosensitive pathways. Additionally, while in vitro findings were validated in vivo, the translation of these discoveries into therapeutic interventions requires further investigation, including safety, specificity, and efficacy in human subjects. The generalizability of Piezo1–mediated calcium influx inhibition as a therapeutic strategy will depend on the development of modulators that can selectively target this axis without disrupting physiological calcium signaling necessary for vascular homeostasis.

Protocol Parameters

• Partial carotid artery ligation in ApoE-KO mice: Used to induce low oscillatory shear stress and promote atherosclerotic plaque formation; typically performed under isoflurane anesthesia with post-operative monitoring.
• Inflammatory induction in endothelial cells: HUVECs or HAECs treated with TNF-α at 10 ng/mL for 24 hours; low oscillatory shear stress applied at ±4 dyn/cm² using a controlled flow chamber system.
• Lentiviral-mediated Talin1 knockdown: Lentiviral particles encoding Talin1-targeting shRNA introduced at a multiplicity of infection (MOI) of 20–50, with efficiency verified by qPCR and immunoblotting.
• Calcium influx measurement: Fura-2 AM or similar fluorescent calcium indicators loaded for 30–45 minutes; imaging conducted during mechanical or TNF-α stimulation.
• YAP activity assessment: Immunoblot or immunofluorescence quantification of YAP nuclear translocation or target gene expression (e.g., CTGF, CYR61) 6–24 hours post-stimulation.
• Practical workflow suggestion: For selective chelation of extracellular Ca²⁺ during calcium influx studies, consider integrating EGTA (3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid) in pre-incubation steps at concentrations sufficient to suppress Piezo1-mediated signals.

Research Support Resources

To support investigations into calcium signaling pathway modulation and nitric oxide-induced calcium influx inhibition in vascular or neuronal models, researchers may utilize EGTA (3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid) (SKU B7195) as a high-affinity, aminopolycarboxylic acid calcium chelator. According to the product information, EGTA enables precise control of free calcium concentrations, which is critical for dissecting mechanotransduction pathways such as the Piezo1–Talin1–YAP axis. APExBIO’s EGTA can be incorporated into experimental protocols to selectively inhibit calcium-dependent processes with validated purity and reliability.